Abstract |
Among numerous studies on synthetic approaches to and the biological activities of vitamin D analogues, we herein focused on falecalcitriol, an analogue of calcitriol (1α,25-dihydroxyvitamin D3), in which a 26,26,26,27,27,27-hexafluoroisopropanol unit has been introduced into the side chain. Falecalcitriol was designed to escape from the metabolism of CYP24A1 and has been used as a drug to treat secondary hyperparathyroidism since 2001. Its metabolite, the 23-hydroxy form, retains biological activity and resistants to further metabolism. Recent developments in synthetic methodologies for introducing the hexafluoroisopropanol unit into the vitamin D CD-ring side chain were described herein.
|
Authors | Fumihiro Kawagoe, Toru Sugiyama, Motonari Uesugi, Atsushi Kittaka |
Journal | The Journal of steroid biochemistry and molecular biology
(J Steroid Biochem Mol Biol)
Vol. 177
Pg. 250-254
(03 2018)
ISSN: 1879-1220 [Electronic] England |
PMID | 28716761
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Copyright | Copyright © 2017 Elsevier Ltd. All rights reserved. |
Chemical References |
- Fluorocarbons
- Propanols
- Acetone
- hexafluoroisopropanol
- hexafluoroacetone
- Calcitriol
- 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3
|
Topics |
- Acetone
(analogs & derivatives, chemistry)
- Calcitriol
(analogs & derivatives, chemistry)
- Fluorocarbons
(chemistry)
- Propanols
(chemistry)
|